Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Leiomyoma × Letrozole × Clear all

Phase

Status

Completed 2 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 9 Polycystic Ovary Syndrome 2 Ovarian Neoplasms 2 Solid Tumor 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Leiomyoma 1 Infertility, Female 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Breast Carcinoma In Situ 1 Abortion, Spontaneous 1

Interventions

vilaprisan 1 ulipristal acetate 1 tibolone 1 telapristone acetate 1 Uterine Myomectomy 1 Tablets 1 Letrozole 1 Iron 1 Holistic Health 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00945360 2012-07-13

Aromatase Inhibitors for Treatment of Uterine Leiomyomas

American University of Beirut Medical Center

Phase 1 Withdrawn

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡